title: Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?
authors.forename: Lung
authors.initials: L
authors.lastname: Chan
mesh_terms: D001562:Benzimidazoles / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000188:drug therapy*; D002543:Cerebral Hemorrhage; D000069604:Dabigatran; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D001562:Benzimidazoles; D011725:Pyridines; D010959:Tissue Plasminogen Activator; D000069604:Dabigatran